Nibec Co Ltd is a Korea-based company primarily engaged in the manufacturing of oral medical products and supplies business. The Company is mainly engaged in the manufacturing of dental bone graft materials and biomaterials. In addition, the Company is engaged in the manufacture of dental antibiotic ointment and syringe-treatment products. The Company sells its products in domestic and overseas markets.

Employees

Sector

Biotechnology & Medical Research

More about the company

Quotes

Date	Price	Change	Volume
26-11-06	₩12,510.00	-5.58%	20,617
26-11-05	₩13,250.00	-0.15%	37,678
26-11-04	₩13,270.00	+0.15%	45,237
26-11-03	₩13,250.00	-1.41%	31,649
26-11-02	₩13,440.00	-1.32%	14,368

End-of-day quote Korea S.E.

More quotes

End-of-day quote Korea S.E. 2026-11-06			5-day change	1st Jan Change
12,510.00 ^KRW	-5.58%		-8.15%	-66.68%

22-11-21	NIBEC Co., Ltd. announced that it has received KRW 25 billion in funding from a group of investors	CI
22-11-17	NIBEC Co., Ltd. announced that it expects to receive KRW 25 billion in funding from a group of investors	CI

Market Cap	142B 104M 93.54M 85.49M 78.04M 147M 9.8B 152M 1.03B 411M 5.23B 391M 383M 16.51B	P/E 2024	-17.8x	P/E 2025	90.9x
Enterprise Value	129B 94.51M 84.77M 77.47M 70.72M 133M 8.88B 137M 934M 372M 4.74B 355M 347M 14.97B	EV / Sales 2024	6.79x	EV / Sales 2025	12.6x
Free-Float	80.7%	Yield 2024 *	-	Yield 2025	-

22-11-21	NIBEC Co., Ltd. announced that it has received KRW 25 billion in funding from a group of investors	CI
22-11-17	NIBEC Co., Ltd. announced that it expects to receive KRW 25 billion in funding from a group of investors	CI
21-09-20	NIBEC Co., Ltd.(KOSDAQ:A138610) added to S&P Global BMI Index	CI
20-12-27	NIBEC Co., Ltd. announced that it has received KRW 10 billion in funding from NH Investment & Securities Co., Ltd., Investment Arm, Samsung Securities Co. Ltd., Investment Arm, KB Securities Co., Ltd., Investment Arm, Korea Investment & Securities Co., Ltd., Investment Arm, Mirae Asset Daewoo Co., Ltd., Investment Arm, DB Financial Investment Co.,Ltd., Investment Arm	CI
20-12-22	NIBEC Co., Ltd. announced that it expects to receive KRW 10 billion in funding from NH Investment & Securities Co., Ltd., Investment Arm, Samsung Securities Co. Ltd., Investment Arm, KB Securities Co., Ltd., Investment Arm, Korea Investment & Securities Co., Ltd., Investment Arm, Mirae Asset Daewoo Co., Ltd., Investment Arm, DB Financial Investment Co.,Ltd., Investment Arm	CI
17-12-25	NIBEC Co., Ltd. announced that it has received KRW 5 billion in funding from Korea Asset Investment Securities Co., Ltd.	CI
17-12-21	NIBEC Co., Ltd. announced that it expects to receive KRW 5 billion in funding from Korea Asset Investment Securities Co., Ltd.	CI
16-03-30	NIBEC Co. Ltd. announced that it has received KRW 6 billion in funding from Hyundai Venture Investment Corp., Daedong Investment Co., Ltd., and other investors.	CI
16-03-29	NIBEC Co. Ltd. announced that it expects to receive KRW 6 billion in funding from Hyundai Venture Investment Corp., Daedong Investment Co., Ltd., and other investors.	CI
15-03-01	NIBEC Co. Ltd. announced that it has received KRW 2 billion in funding.	CI
15-02-25	NIBEC Co. Ltd. announced that it expects to receive KRW 2 billion in funding.	CI

1 day	-5.58%
1 week	-8.15%
Current month	-8.15%
1 month	-22.15%
3 months	-19.08%
6 months	-47.33%
Current year	-66.68%

NIBEC Co., Ltd. Stock

Stocks

A138610

KR7138610001

Biotechnology & Medical Research

Valuation: NIBEC Co., Ltd.

Chart: NIBEC Co., Ltd.

Latest news: NIBEC Co., Ltd.

Quotes and Performance

Price Extremes

Managers and Directors: NIBEC Co., Ltd.

Bio Medical Devices

Financials

Company Profile

Quotes

1 week	12,180	13,980
1 month	12,180	16,580
Current year	11,230	40,400
1 year	11,230	54,300
3 years	11,230	54,300
5 years	11,230	54,300
10 years	4,800	55,500

Manager	Title	Age	Since
Jong-Pyeong Jeong CEO	Chief Executive Officer	80	2003-12-31
Yoon-Jeong Park PRN	Corporate Officer/Principal	55	-
Yang-Jo Seol AUD	Comptroller/Controller/Auditor	58	2012-03-29

Director	Title	Age	Since
Jong-Pyeong Jeong BRD	Director/Board Member	80	2003-12-31
Yoon-Jeong Park BRD	Director/Board Member	55	-
Joo-Yeon Lee BRD	Director/Board Member	51	-

Add to a list 0 selected To use this feature you must be a member Log in Sign up	Change	5-day change	1-year change	3-year change	Capi.($)
NIBEC CO., LTD.	-5.58%	-8.15%	-67.80%	-25.54%	104M
WUXI APPTEC CO., LTD.	-4.83%	+3.51%	+55.00%	+63.79%	66.7B
ARGENX SE	+0.02%	+1.07%	+11.72%	+75.63%	56.88B
LONZA GROUP AG	-1.34%	+2.98%	+25.08%	+100.18%	56.53B
BEONE MEDICINES AG	+5.09%	+9.89%	+27.19%	+105.85%	46.49B
IQVIA HOLDINGS INC.	+2.62%	+1.68%	+29.16%	+35.86%	44.8B
REVOLUTION MEDICINES, INC.	+8.24%	+0.51%	+215.16%	+794.74%	41.59B
CELLTRION, INC.	-1.86%	+10.13%	+28.14%	+55.48%	35.35B
GENMAB A/S	-2.97%	-9.84%	+90.91%	+73.49%	33.29B
INSMED INCORPORATED	+5.19%	+1.62%	-39.69%	+368.87%	25.1B
Average	+0.46%	+1.69%	+37.49%	+164.84%	40.68B
Weighted average by Cap.	+0.65%	+3.07%	+49.87%	+165.83%

	2024	2025
Net sales	24.55B 18M 16.15M 14.76M 13.47M 25.38M 1.69B 26.18M 178M 70.93M 903M 67.57M 66.12M 2.85B	32.72B 23.99M 21.52M 19.67M 17.95M 33.82M 2.26B 34.89M 237M 94.53M 1.2B 90.06M 88.13M 3.8B
Net income	-9.33B -6.84M -6.13M -5.61M -5.12M -9.64M -643M -9.95M -67.58M -26.95M -343M -25.67M -25.12M -1.08B	4.64B 3.4M 3.05M 2.79M 2.55M 4.8M 320M 4.95M 33.63M 13.41M 171M 12.78M 12.5M 539M
Net Debt	-7.34B -5.38M -4.83M -4.41M -4.03M -7.59M -506M -7.83M -53.2M -21.21M -270M -20.21M -19.78M -853M	-13.34B -9.78M -8.77M -8.02M -7.32M -13.79M -919M -14.22M -96.62M -38.53M -491M -36.71M -35.92M -1.55B